TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: NT-proBNP Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Response rate of treatment patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prediction accuracy to detect MCR participants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of antibodies against hepatitis C virus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: CRC susceptibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: CRC prognosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Mean CDE (Cumulated Dissipated Energy)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Concentration (Cmax) of BIIB122
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration-Time Curve From Time Zero to Time of the Last Measurable Concentration (AUClast) of BIIB122
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration-Time Curve From Time Zero to Infinity (AUCinf) of BIIB122
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Numeric Rate Score (NRS)
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Sedation levels during endoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in Loneliness Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Successful insertion and measurement of esophageal pressures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perioperative adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Volitional Ankle Control-Tapping Task Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ankle Spasticity-Ankle Clonus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neuromuscular outcomes
Primary endpoint: Change in PTSD symptoms scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in microbiota community structure & function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in 2-arachidonoyl-glycerol (2-AG) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in N-arachidonoylethanolamine (AEA) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in N-palmitoylethanolamine (PEA) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in N-oleoylethanolamine (OEA) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in N-palmitoylethanolamine (DHEA) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of subjects achieving 30% reduction of MPN-SAF Total symptom score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Alzheimers Disease Assessment Scale Cognitive section (ADAS-Cog)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Changes in Retinal measured in microliters per second (ul/s)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Executive Function using the Dimensional Card Sort Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in the Six-Minute Walk Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of endovascular inferior mesenteric artery embolisation
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical evaluation of the crown
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression of disease
Endpoint domain: Mortality/survival
Primary endpoint: Surgical outcomes post-hepatectomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of babies who die or survive with moderate or severe disability
Endpoint domain: Mortality/survival
Primary endpoint: mother-infant bonding
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Biofeedback effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in muscle strength and function by manual muscle testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in muscle strength and function by hand-held dynamometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in muscle strength and function by quick motor function test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in muscle strength and function by 6-minute walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in pulmonary function by forced vital capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Plasma concentration of Agomelatine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma concentration of Agomelatine metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parents' level of knowledge about epilepsy
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Health Promoting and Protective Behaviors
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change of Tinnitus Functional Index Scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Primary Lung Graft Dysfunction (PGD) grade 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardio respiratory fitness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Collective Efficacy
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Safety (number/presence of intervention-related serious adverse events)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in ASD symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Acne Symptom and Impact Scale Questionnaire (ASIS) Domain Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pharmacokinetics Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cohen Mansfield Agitation Index
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Hemodynamic events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Vascular density in central and peripheral retina
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Safety and tolerability of SCIO-469
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Plasma TNF-a
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Plasma IL-6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Core temperature response to heat tolerance test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Natural killer cell phenotype
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reproducibility by inter- and intraobserver agreement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time in Range (TIR) of blood glucose values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Magnitude of noxious-evoked brain activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cumulative incidences of early treatment related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Disease response to the treatment during induction phase to steroids
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disease response to the treatment during induction phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of Streptococcus pneumoniae serotype
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Preconditioning Response as Measured by a Composite of Biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Left ventricular End-Systolic Volume (LVESV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Six Minute Hall Walk (6MHW)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minnesota Living with Heart Failure quality of Life Score (MLWHF QOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Major Adverse Respiratory and Cardiovascular Events (MARCE)
Endpoint domain: Adverse events/effects
Primary endpoint: simple inflammatory markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Protein oxidation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Metabolic supply proportion of glucose, fat, protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline in Montreal Cognitive Assessment Scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in BDNF level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in alcohol consumption as assessed by Alcohol Timeline Follow Back (TLFB-Alcohol)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in alcohol craving as assessed by the Visual Analog Scale for Craving (VAS 0-10 Craving)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients who proceeded to surgical resection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of participants with relapse
Endpoint domain: Mortality/survival
Primary endpoint: Circulating circRNA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative incidence rate of recurrent ischemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Oxidative DNA damage repair capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Karolinska Sleepiness Scale
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Renal elimination clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Fasting plasma phenylalanine concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Glomerular Filtration Rate (eGFR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Serum Kidney Function Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Number of patients presenting Stroke Post Traumatic Disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total insertion time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of RT-PCR confirmed symptomatic COVID-19 cases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: quantitative anti-sars-cov-2 titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Sensitivity and specificity for gonorrhoea, chlamydia and LGV diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: perceived nursing compassion
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: patient depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Response Rate of Combination Therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in metabolic flexibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Caregiving self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Diet Quality Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients overweight and obese measured by Body mass index (BMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blood/serum nutrient levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Dark adaptometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Roland Morris Disability Questionnaire (RDQ)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: SF 36 health questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Functional rating index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Post-endodontic pain level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of psychological well-being
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Adverse Events Assessment using CTCAE v5.0
Endpoint domain: Adverse events/effects
Primary endpoint: GA lesion size change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Overall retinal sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Dyspnea score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Moderate or more severe COPD exacerbation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of occlusal contacts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of device and procedure-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Galactose uptake in skeletal muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Subjective functional recovery
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Absolute risk of second revision of the cup
Endpoint domain: Adverse events/effects
Primary endpoint: score on the extended Glasgow Outcome Scale (eGOS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Proportion of patients eligible enrolled
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Changes of Freezing of Gait severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overactive Bladder Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: postoperative morbimortality rate
Endpoint domain: Mortality/survival
Primary endpoint: Antithrombin III level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation of f with IF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pathological remission rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incontinence Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change from baseline on the First-Episode Social Functioning Scale (School subscale)
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Mean change from baseline on the First-Episode Social Functioning Scale (Relationships and social activities at school subscale)
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Mean change from baseline on the Rubric tool
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Revised Children's Anxiety and Depression Scale - Parent Revised Short Version (RCADS-P-S)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Revised Children's Anxiety and Depression Scale - Child Revised Short Version (RCADS-C-S)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Parental Stress Scale (PSS) as measured by Likert Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of hypertensive crisis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: number of patients duly followed up
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Accuracy of MSCT in congenital cardiovascular anomalies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean change in depressive symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in use of BZRA medication
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Frequency of adverse birth outcomes
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Type-1 Diabetes Distress Score (T1-DDS-7)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Volume of distribution total (VT) of the PET radioligand
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completeness of the CHAMP tool
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to fill out the CHAMP tool
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Satisfaction with the CHAMP tool
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Reduction in severity and duration of symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prediction of rejection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Withdrawal of corticosteroids
Endpoint domain: Adverse events/effects
Primary endpoint: Mean Estimated Glomerular Filtration rate (eGFR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Long-term safety of HSK16149 capsules
Endpoint domain: Adverse events/effects
Primary endpoint: Prescription medication access
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Treatment retention/discontinuation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of post-operative irritative voiding symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Response to in-lab exercise - body image
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Response to in-lab exercise - affect
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Response to in-lab exercise - biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Behavior and Feelings Survey (BFS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Functional Top Problems Assessment (TPA)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Urinary health-related QoL
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Bowel health-related QoL
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Sexual health-related QoL
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Hormonal health-related QoL
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: QoL (combined score of EPIC-26)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Intention to receive COVID-19 vaccine
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cmax,ss of DWJ1558
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUCt of DWJ1558
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Apparent terminal elimination half-life (t½)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proliferation capacity of muscle regeneration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Differentiation capacity of muscle regeneration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Promotores' Social Media Self-Efficacy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in outdoor worker sun safety behaviors
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Self-reported severe hypoglycemia
Endpoint domain: Adverse events/effects
Primary endpoint: Essential Tremor Rating Assessment Scale (TETRAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Body mass index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in maximal oxygen consumption (VO2max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evolution of blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Evolution of HbA1c
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Evolution of weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes